Five IPOs are scheduled for the week of February 4. The full IPO calendar is available here.
Based in Englewood Cliffs, NJ, ConnectOne Bancorp (NASDAQ:CNOB) scheduled a $44 million IPO with a market capitalization of $131million at a price range mid-point of $27.50, for Tuesday, February 12, 2013.
CNOB is a small New Jersey bank that generated a 25% increase in net interest income for the nine months ended September 2012 vs 2011, along with a 27% increase in net profit.
Based in Rutherford, NJ, Cancer Genetics (NASDAQ:CGIX) scheduled a $35 million IPO with a market capitalization of $80 million at a price range mid-point of $7, for Wednesday, February 13, 2013.
CBIX is an early-stage diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis and response to treatment (theranosis) of cancer.
Based in Vero Beach, FL, Orchid Island Capital (NYSE:ORC) scheduled a $36 million IPO with a market capitalization of $50 million at a price range mid-point of $15, for Thursday, February 14, 2013.
ORC is a Mortage REIT. ORC postponed an IPO planned for July 22, 2012, discussed here.
The sponsor is Bimini, which has considerable problems of its own.
Based in San Francisco, CA, Xoom (NASDAQ:XOOM) scheduled a $82 million IPO with a market capitalization of $438 million at a price range mid-point of $14, for Friday, February 15, 2013.
XOOM focuses on small Internet money transfers for immigrants in the US, sent to their overseas relatives. The average customer sent 8.5 transaction during 2012, and sent a total of $491.
Based in Vista, CA, AutoGenomics (NASDAQ:AGMX) scheduled a $60 million with a market capitalization of $168 million at a price range mid-point of $10, for the week of February 11, 2013.
AGMX is held over from last week.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.